Discontinue triamcinolone and obtain a skin biopsy immediately to rule out extramammary Paget's disease or other malignancy
A peeling, itchy, spreading inframammary rash in a 73-year-old woman that has failed to respond to triamcinolone cream after a reasonable trial period is a red flag for possible malignancy, particularly extramammary Paget's disease or mammary Paget's disease, and requires tissue diagnosis before any further treatment.
Immediate Action Required
Stop the triamcinolone cream immediately. Continued use of topical steroids on an undiagnosed chronic rash can mask underlying malignancy and delay critical diagnosis 1, 2. The fact that this rash is spreading despite steroid treatment is particularly concerning.
Diagnostic Workup
Essential Steps:
- Skin biopsy with immunohistochemistry is mandatory for any chronic, refractory inframammary or areolar rash in an elderly woman 1, 2
- Look specifically for:
- Pagetoid cells (large pale pleomorphic cells with atypical nuclei)
- Immunostaining for CK7, CEA, GCDFP-15, and HER2 2
- Wood's lamp examination to evaluate for coral-red fluorescence suggesting erythrasma 3
- Bacterial and fungal cultures if infection is suspected 3
Clinical Red Flags Present in This Case:
- Age 73 (high-risk demographic for Paget's disease)
- Inframammary location (classic site for both erythrasma and Paget's disease)
- Failure to respond to appropriate-strength topical steroid
- Progressive spreading despite treatment
Why This Matters
Extramammary Paget's disease commonly presents as a chronic eczematous or pruritic plaque that mimics benign dermatoses and is frequently misdiagnosed as dermatitis, leading to months or years of inappropriate topical steroid treatment 2. In one reported case, a patient was treated unsuccessfully with topical steroids, antifungals, and antibiotics for 3 years before correct diagnosis 2. Similarly, mammary Paget's disease can present with areolar erythema without obvious nipple involvement and may be treated with steroids at outside clinics before proper diagnosis 1.
If Biopsy is Negative for Malignancy
Only after excluding malignancy should you consider these alternative diagnoses and treatments:
For Erythrasma (if Wood's lamp positive or culture confirms):
- First-line: Oral erythromycin 250mg four times daily for 14 days (cure rates up to 100%) 3
- Alternative: Topical clindamycin solution or clarithromycin 3
- Erythrasma is the most common cause of inframammary infections and is more prevalent in elderly patients with diabetes 3
For Inflammatory Dermatitis (if biopsy shows eczematous changes):
- Avoid alcohol-containing products and excessive washing 4
- Emollients with urea 5-10% twice daily to address xerosis 4, 5
- Medium-potency topical steroid (NOT triamcinolone again—consider prednicarbate 0.02% cream) applied twice daily for maximum 2 weeks 4
- Oral antihistamines (cetirizine, loratadine, or fexofenadine) for pruritus 4
- Reassess after 2 weeks—if no improvement, refer to dermatology 4
For Secondary Bacterial Infection:
- If yellow crusting, discharge, or painful lesions develop: bacterial culture and oral antibiotics (flucloxacillin or doxycycline 100mg twice daily for 14 days) 6, 4
Critical Pitfalls to Avoid
Never continue topical steroids on an undiagnosed chronic rash in an elderly patient—this is the most common error leading to delayed diagnosis of Paget's disease 1, 2
Do not assume treatment failure means you need a stronger steroid—triamcinolone 0.1% is already a potent (Class III) steroid 7; failure suggests wrong diagnosis, not inadequate potency
Gold Bond powder is not therapeutic for inflammatory or infectious conditions—it may provide symptomatic relief but does not treat underlying pathology 8
Spreading despite treatment is never normal—this mandates diagnostic workup, not empiric treatment escalation
Bottom Line
This patient needs a dermatology referral and skin biopsy within 1-2 weeks, not another topical treatment trial. The combination of age, location, treatment failure, and progressive spread creates sufficient concern for malignancy that tissue diagnosis takes absolute priority over empiric therapy.